Free shipping on all orders over $ 500

Laquinimod

Cat. No. M1803

All AbMole products are for research use only, cannot be used for human consumption.

Laquinimod Structure
Synonym:

ABR-215062

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
2mg USD 26 In stock
5mg USD 45 In stock
10mg USD 70 In stock
25mg USD 90 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Laquinimod (ABR-215062) is a new orally active immunoregulator effectively inhibits development and relapses of experimental autoimmune encephalomyelitis. EAE shares important immunological and clinical features with multiple sclerosis (MS). Doses of 16, 1.6 and 0.16 mg/kg/day laquinimod dose-dependently inhibited disease and showed better disease inhibitory effects as compared to roquinimex (Linomide). Furthermore, laquinimod inhibited the inflammation of both CD4+ T cells and macrophages into central nervous tissues, i.e. the spinal cord. It also changed the cytokine balance in favour of TH2/TH3 cytokines IL-4, IL-10 and TGF-beta.

Chemical Information
Molecular Weight 356.8
Formula C19H17ClN2O3
CAS Number 248281-84-7
Solubility (25°C) DMSO 70 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Toubi et al. J Neuroimmunol. Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis.

[2] Brück et al. Acta Neuropathol. Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.

[3] Mishra et al. Am J Pathol. Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod.

[4] Aharoni et al. J Neuroimmunol. Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.

Related Immunology/Inflammation Products
Mycophenolic acid

Mycophenolic acid is an immunosuppressant agent used to prevent rejection in organ transplantation.

TAPI-1

TAPI-1 is an ADAM17/TACE inhibitor that blocks shedding of cytokine receptors with IC50 value of 8.09 microM.

Dipsacoside B

Dipsacoside B is extracted from Lonicara confusa DC. dried buds and flowers. Dipsacoside B showes strong antimicrobial activity.

Naringenin

Naringenin is the predominant flavanone in Citrus reticulata Blanco, it displays strong anti-inflammatory and antioxidant activities. Naringenin has anti-dengue virus (DENV) activity.

Daratumumab

Daratumumab (Daratumumab) is a first-in-class, specific anti-CD38 monoclonal antibody (IgG1). (for human or immunodeficient mice).

  Catalog
Abmole Inhibitor Catalog




Keywords: Laquinimod, ABR-215062 supplier, Immunology/Inflammation, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.